|
Market Closed -
Other stock markets
|
Pre-market 12:54:37 pm | |||
| 5.898 EUR | -1.70% |
|
5.895 | -0.05% |
| 13/01 | Evotec says Michael Kaufman holds 5.03% of total voting rights and instruments in Evotec | RE |
| 08/01 | Evotec Receives Gates Foundation Grant to Deploy AI in Optimizing Monoclonal Antibodies | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €8.46 | +43.44% | 5 | ||||||
| CHF 677.74 | +24.68% | 23 | ||||||
| $259.65 | +11.11% | 20 | ||||||
| $404.19 | +20.91% | 24 | ||||||
| ₩2,35,751.77 | +13.89% | 22 | ||||||
| $100.79 | -13.28% | 19 | ||||||
| $545.75 | -9.4% | 12 | ||||||
| €67.85 | -3.56% | 15 | ||||||
| $205.69 | +16.49% | 16 | ||||||
| $230.53 | +25.47% | 15 | ||||||
| $87.92 | +31.65% | 12 | ||||||
| $90.63 | +16.89% | 22 | ||||||
| $213.21 | -2.28% | 14 | ||||||
| $70 | +0.63% | 12 | ||||||
| $52.87 | -4.65% | 13 | ||||||
| Average | 15,917.8 | +11.47% | 16 | ||||||
| Weighted average by Cap. | 24,772.78 | +11.70% | 19 |
- Stock Market
- Equities
- EVT Stock
- Sector Evotec SE
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition